|
WHSC1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.77395900588817E-15 |
| Normal-vs-Stage2 |
1.86169968330319E-10 |
| Normal-vs-Stage3 |
1.55431223447522E-15 |
| Normal-vs-Stage4 |
2.87991852587766E-13 |
| Stage1-vs-Stage2 |
4.263600E-01 |
| Stage1-vs-Stage3 |
1.302580E-01 |
| Stage1-vs-Stage4 |
1.136630E-01 |
| Stage2-vs-Stage3 |
7.676400E-01 |
| Stage2-vs-Stage4 |
6.920200E-01 |
| Stage3-vs-Stage4 |
8.947600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.006860E-04 |
| Normal-vs-Asian |
5.89439608233988E-11 |
| Caucasian-vs-AfricanAmerican |
1.271770E-01 |
| Caucasian-vs-Asian |
7.240400E-01 |
| AfricanAmerican-vs-Asian |
1.984420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.351000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64124269730337E-12 |
| Normal-vs-Age(41-60Yrs) |
9.43689570931383E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(81-100Yrs) |
3.89630000000585E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.912400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.065600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.976200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.459400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.994600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.537600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.727800E-02 |
| Classical-VS-Follicular |
8.754400E-02 |
| Classical-VS-Other |
2.869800E-01 |
| Classical-VS-Normal |
1.6251444634463E-12 |
| Tall-VS-Follicular |
4.092400E-01 |
| Tall-VS-Other |
9.509600E-01 |
| Tall-VS-Normal |
1.94499971684081E-12 |
| Follicular-VS-Other |
7.672600E-01 |
| Follicular-VS-Normal |
1.2730039244957E-11 |
| Other-VS-Normal |
3.576300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.28055377202463E-12 |
| N0-vs-N1 |
5.116200E-01 |
|
|
